Mark Plavsic

Company: Fate Therapeutics
Job title: Chief Technical Officer
Seminars:
Manufacturing of Next-Generation Cellular Immunotherapies using a Novel Induced Pluripotent Stem Cell Platform 11:45 am
Outline advantage of iPSC derived platform Discuss some challenges Review potential scale up opportunitiesRead more
day: Day One
Panel: The Bigger Picture: The Priorities of iPSC Based Cell Therapy Manufacturing 8:30 am
Identifying areas of focus during different developmental stages to ensure successful iPSC production and scale-up Managing operations and mitigating risk to ensure smooth transition through preclinical and clinical phasesRead more
day: Day One